| Lastest Insider Transactions Of Maze Therapeutics, Inc. ( MAZE ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-01-22 | Sell | 5,000 | 45.52 | 227,612 | 2026-01-26 16:10:37 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-01-22 | Option Exercise | 5,000 | 10.42 | 52,100 | 2026-01-26 16:10:37 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-07 | Sell | 25,156 | 40.20 | 1,011,299 | 2026-01-09 16:51:26 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-07 | Option Exercise | 25,156 | 10.42 | 262,126 | 2026-01-09 16:51:26 |
| MAZE | Maze Therapeutics, Inc. | Sohn Catherine A. | Directior | 2026-01-06 | Option Exercise | 29,413 | 10.42 | 306,483 | 2026-01-08 16:30:38 |
| MAZE | Maze Therapeutics, Inc. | Sohn Catherine A. | Directior | 2026-01-06 | Sell | 29,413 | 39.07 | 1,149,054 | 2026-01-08 16:30:38 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-02 | Sell | 4,844 | 40.39 | 195,668 | 2026-01-06 16:31:52 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-02 | Option Exercise | 4,844 | 10.42 | 50,474 | 2026-01-06 16:31:52 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2025-12-29 | Sell | 72,500 | 40.56 | 2,940,800 | 2025-12-31 16:24:23 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2025-12-29 | Option Exercise | 72,500 | 10.42 | 755,450 | 2025-12-31 16:24:23 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Sell | 45,000 | 40.56 | 1,825,355 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Option Exercise | 45,000 | 10.42 | 468,900 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Sell | 45,000 | 40.56 | 1,825,355 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Option Exercise | 45,000 | 10.42 | 468,900 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2025-12-29 | Sell | 15,000 | 40.41 | 606,173 | 2025-12-31 16:20:07 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2025-12-29 | Option Exercise | 15,000 | 10.42 | 156,300 | 2025-12-31 16:20:07 |
| MAZE | Maze Therapeutics, Inc. | SCHELLER RICHARD H | Directior | 2025-09-15 | Sell | 20,744 | 22.37 | 464,035 | 2025-09-16 16:26:27 |
